193 related articles for article (PubMed ID: 32162861)
1. The Trend of ripk1/ripk3 and mlkl Mediated Necroptosis Pathway in Patients with Different Stages of Prostate Cancer as Promising Progression Biomarkers.
Heidaryan F; Bamehr H; Babaabasi B; Emamvirdizadeh A; Mohammadzadeh N; Khalili A
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162861
[TBL] [Abstract][Full Text] [Related]
2. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
3. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
[TBL] [Abstract][Full Text] [Related]
4. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
5. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
[TBL] [Abstract][Full Text] [Related]
6. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
[TBL] [Abstract][Full Text] [Related]
7. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
[TBL] [Abstract][Full Text] [Related]
8. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis.
Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W
Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894
[TBL] [Abstract][Full Text] [Related]
9. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
Front Immunol; 2018; 9():1818. PubMed ID: 30154785
[TBL] [Abstract][Full Text] [Related]
10. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer.
Lin P; Lin C; He R; Chen H; Teng Z; Yao H; Liu S; Hoffman RM; Ye J; Zhu G
Cell Death Dis; 2023 Jan; 14(1):6. PubMed ID: 36604411
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.
Newton K; Wickliffe KE; Dugger DL; Maltzman A; Roose-Girma M; Dohse M; Kőműves L; Webster JD; Dixit VM
Nature; 2019 Oct; 574(7778):428-431. PubMed ID: 31511692
[TBL] [Abstract][Full Text] [Related]
12. RIPK1 inhibits ZBP1-driven necroptosis during development.
Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
[TBL] [Abstract][Full Text] [Related]
13. TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor.
Wang L; Chang X; Feng J; Yu J; Chen G
Front Cell Dev Biol; 2019; 7():393. PubMed ID: 32039207
[TBL] [Abstract][Full Text] [Related]
14. Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis.
Karlowitz R; van Wijk SJL
FEBS J; 2023 Jan; 290(1):37-54. PubMed ID: 34710282
[TBL] [Abstract][Full Text] [Related]
15. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
16. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
[TBL] [Abstract][Full Text] [Related]
17. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
[TBL] [Abstract][Full Text] [Related]
18. Necroptosis-driving genes
Nicolè L; Sanavia T; Cappellesso R; Maffeis V; Akiba J; Kawahara A; Naito Y; Radu CM; Simioni P; Serafin D; Cortese G; Guido M; Zanus G; Yano H; Fassina A
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264437
[TBL] [Abstract][Full Text] [Related]
19. Loss of periodontal ligament fibroblasts by RIPK3-MLKL-mediated necroptosis in the progress of chronic periodontitis.
Shi J; Li J; Su W; Zhao S; Li H; Lei L
Sci Rep; 2019 Feb; 9(1):2902. PubMed ID: 30814594
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of pro-necroptotic molecules blunts necroptosis during myogenesis.
Kim TY; Kang JH; Lee SB; Kang TB; Lee KH
Biochem Biophys Res Commun; 2021 Jun; 557():33-39. PubMed ID: 33862457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
